Literature DB >> 9450890

Clinical differences between North African and Iraqi Jews with familial Mediterranean fever.

E Pras1, A Livneh, J E Balow, E Pras1, D L Kastner, M Pras, P Langevitz.   

Abstract

Familial Mediterranean fever (FMF) is an autosomal recessive disease causing attacks of fever and serositis. The gene causing this disease, designated MEFV, was mapped to the short arm of chromosome 16, but has not yet been cloned. North African and Iraqi Jews constitute the two largest population groups suffering from the disease in Israel. In this report we compared the severity of the disease between these two populations. North African Jews were found to have a more severe disease manifested by an earlier age of onset, an increase in frequency and severity of joint involvement, a higher incidence of erysipelas-like erythema, and a higher dose of colchicine required to control symptoms. The involvement of additional genes, environmental factors, and different mutations in MEFV, may explain the clinical variation in disease severity between these two population groups.

Entities:  

Mesh:

Year:  1998        PMID: 9450890     DOI: 10.1002/(sici)1096-8628(19980113)75:2<216::aid-ajmg20>3.0.co;2-r

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  56 in total

1.  Diagnosis. Severity scoring system for paediatric FMF.

Authors:  Avi Livneh
Journal:  Nat Rev Rheumatol       Date:  2012-04-17       Impact factor: 20.543

2.  Familial Mediterranean fever in Syrian children: phenotype-genotype correlation.

Authors:  Rami A Jarjour; Sumaya Al-Berrawi
Journal:  Rheumatol Int       Date:  2014-08-24       Impact factor: 2.631

3.  ABCC6 is unlikely to be a modifier gene for familial Mediterranean fever severity.

Authors:  N Chassaing; I Touitou; D Cattan; P Calvas
Journal:  J Genet       Date:  2007-12       Impact factor: 1.166

4.  The evaluation of anxiety, depression and quality of life scores of children and adolescents with familial Mediterranean fever.

Authors:  Arzu Önal Sönmez; Hafize Emine Sönmez; Mustafa Çakan; Mesut Yavuz; Gonca Keskindemirci; Nuray Aktay Ayaz
Journal:  Rheumatol Int       Date:  2020-01-25       Impact factor: 2.631

5.  Peripapillary retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in adult-onset familial Mediterranean fever.

Authors:  Sait Alim; Mehmet Esen; Ayşe Kevser Demir; Selim Demir; Hüseyin Ortak; Alper Güneş; Tufan Alatli; Helin Deniz Demir
Journal:  Int Ophthalmol       Date:  2017-01-21       Impact factor: 2.031

6.  Different pharmaceutical preparations of colchicine for Familial Mediterranean Fever: are they the same?

Authors:  Hakan Emmungil; Ufuk İlgen; Sezin Turan; Samet Yaman; Orhan Küçükşahin
Journal:  Rheumatol Int       Date:  2019-08-28       Impact factor: 2.631

7.  Severity scoring system for paediatric FMF.

Authors:  Gokhan Kalkan; Erkan Demirkaya; Seza Ozen
Journal:  Nat Rev Rheumatol       Date:  2012-09-11       Impact factor: 20.543

8.  The effect of colchicine and disease severity on physical growth in children with familial Mediterranean fever.

Authors:  Tuba Çelen Yoldaş; Nilgün Çakar; Özge Başaran; Banu Acar; Nermin Uncu; F Şemsa Çaycı
Journal:  Clin Rheumatol       Date:  2015-09-18       Impact factor: 2.980

9.  Familial mediterranean Fever: a retrospective clinical and molecular study in the East of anatolia region of Turkey.

Authors:  Ebru Onalan Etem; Ebru Etem; Sukriye Derya Deveci; Deniz Erol; Huseyin Yuce; Halit Elyas
Journal:  Open Rheumatol J       Date:  2010-01-29

10.  Mean platelet volume in children with familial Mediterranean fever.

Authors:  Balahan Makay; Zeynep Türkyilmaz; Erbil Unsal
Journal:  Clin Rheumatol       Date:  2009-03-13       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.